Navigation Links
Forbes Announces IntegriChain in Top 20 on List of America's Most Promising Companies
Date:11/30/2011

PRINCETON, N.J., Nov. 30, 2011 /PRNewswire/ -- IntegriChain, Inc., a commercial insight provider supporting the pharmaceutical industry was identified by Forbes as #19 on the list of America's Most Promising Companies. IntegriChain offers 3-5 year subscription based services to help customers improve order forecasting, order monitoring, better manage their sales and marketing activates, and production planning. IntegriChain has grown 60% over the past three years and plans on continuing to do so over the next 3-4, achieving 70-75% of the market share on data coverage across all of US life science.

(Logo:  http://photos.prnewswire.com/prnh/20111130/NY15137LOGO )

"We are truly in some rarified air on this list," said IntegriChain CEO Kevin Leininger. "I am thrilled that we have been selected." Leininger was selected to participate in Forbes' VIP Entrepreneurs and Celebrity Mentor round table discussion and one-on-one consultation, the video of which can be found on Forbes.com.

Forbes' list of America's Most Promising Companies features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital.

"Sizing up younger, privately held companies is hard: Their fortunes can change very quickly and there's a dearth of public data," says Forbes Executive Editor Brett Nelson. "We took a more comprehensive approach to evaluate their health and potential."

To sharpen its search, Forbes teamed up with CB Insights, a Manhattan-based data firm that tracks investment in high-growth private companies. With $650,000 in grants from the National Science Foundation, CB has developed complex software called Mosaic that mines myriad online sources (from press releases and social networks to job boards and court filings) to come up with one, algorithmically derived score that measures a private company's health. Forbes married Mosaic's data-crunching with old-fashioned reporting to assemble a list of rising stars with bright growth prospects. To view the complete the list, please visit www.forbes.com/ampc.

About IntegriChain, Inc. is a next-generation life sciences informatics company.  IntegriChain's industry leading platform for channel data integration and enrichment delivers pharmaceutical and biotech manufacturers marketplace insight with unprecedented speed and transparency.  Located in Princeton, New Jersey, IntegriChain is a recent recipient of the Inc 500, Red Herring 100 and New Jersey Technology Council's Early Stage Company of the Year.

Contact: Shannon M Harder, Marketing Coordinator, IntegriChain, Inc. Phone: 609-806-1536 // smh@integrichain.com // www.integrichain.com


'/>"/>
SOURCE IntegriChain, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Named to the Forbes 2009 List of the 200 Best Small Companies in America
2. Young Innovations, Inc. is Named to Forbes List of Americas 200 Best Small Companies
3. Neogen Again Named to Forbes List of Best Small Companies
4. Luminex Corporation Ranked One of the 25 Fastest-Growing Technology Companies in America by Forbes for Third Consecutive Year
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 ... Financier Sanofi, leader mondial ... ses résultats pour le premier trimestre ... Jérôme Contamine, commente les résultats du ... perspectives pour le reste de l,année. ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
Breaking Medicine Technology:
(Date:4/30/2016)... Indianapolis, Indiana (PRWEB) , ... April 30, 2016 , ... ... USA Wrestling as they go for gold in Rio. Under the care of ... including two golds! , In an unprecedented showing, Maximized Living is sending the largest ...
(Date:4/29/2016)... Hollywood, Fl (PRWEB) , ... April 29, 2016 ... ... was recently notified by the Accreditation Council for Graduate Medical Education (ACGME) that ... , This is the first accreditation of three residency programs that Memorial ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") addresses ... Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, author ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Spine Team Texas, ... is proud to announce one of their physicians has been invited to be a ... (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. ...
(Date:4/29/2016)... ... ... type of skin cancer. Although only about 1 percent of skin cancer cases are melanoma, ... are expected to die of melanoma this year. The risk increases with age, and while ... diagnosed cancers in young women. A recent breakthrough in genetic studies may give doctors the ...
Breaking Medicine News(10 mins):